Semaglutide GLP-1 works by mimicking a hormone in your body that causes the pancreas to release insulin, thereby controlling blood sugar
Larsen MT, Kuhlmann M, Hvam ML, Howard KA
doi: 10.1056/NEJMp2400978 Summary Keywords GIP, GLP-1, GLP-1RA, tirzepatide, diabetes, obesity, cardiovascular disease Citation Liu QK (2024) Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
A dose-dependent response has been observed with half (125 mg), normal (250 mg), and double (500 mg) doses, with higher doses producing greater blood sugar blunting effects
Pendulum plus creatine or amino acids